- Home
- MTEN vs PYPD Comparison
MTEN vs PYPD Comparison
Compare MTEN & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEN
- PYPD
- Stock Information
- Founded
- MTEN 2015
- PYPD 2008
- Country
- MTEN China
- PYPD Israel
- Employees
- MTEN N/A
- PYPD N/A
- Industry
- MTEN Building Products
- PYPD Medical/Dental Instruments
- Sector
- MTEN Industrials
- PYPD Health Care
- Exchange
- MTEN Nasdaq
- PYPD Nasdaq
- Market Cap
- MTEN 82.6M
- PYPD 34.8M
- IPO Year
- MTEN 2024
- PYPD 2020
- Fundamental
- Price
- MTEN $12.03
- PYPD $3.42
- Analyst Decision
- MTEN
- PYPD Strong Buy
- Analyst Count
- MTEN 0
- PYPD 5
- Target Price
- MTEN N/A
- PYPD $12.00
- AVG Volume (30 Days)
- MTEN 59.1K
- PYPD 58.1K
- Earning Date
- MTEN 10-18-2025
- PYPD 11-12-2025
- Dividend Yield
- MTEN N/A
- PYPD N/A
- EPS Growth
- MTEN N/A
- PYPD N/A
- EPS
- MTEN N/A
- PYPD N/A
- Revenue
- MTEN $10,120,257.00
- PYPD N/A
- Revenue This Year
- MTEN N/A
- PYPD N/A
- Revenue Next Year
- MTEN N/A
- PYPD N/A
- P/E Ratio
- MTEN N/A
- PYPD N/A
- Revenue Growth
- MTEN 23.03
- PYPD N/A
- 52 Week Low
- MTEN $3.20
- PYPD $2.30
- 52 Week High
- MTEN $26.03
- PYPD $3.93
- Technical
- Relative Strength Index (RSI)
- MTEN 44.06
- PYPD 47.79
- Support Level
- MTEN $10.27
- PYPD $3.42
- Resistance Level
- MTEN $12.20
- PYPD $3.53
- Average True Range (ATR)
- MTEN 0.87
- PYPD 0.11
- MACD
- MTEN 0.08
- PYPD 0.00
- Stochastic Oscillator
- MTEN 52.32
- PYPD 43.30
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.